Literature DB >> 22922741

Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and Alzheimer's disease.

Jenny Junkkila1, Sakari Oja, Matti Laine, Mira Karrasch.   

Abstract

AIM: To compare the diagnostic accuracy of a computerized test, the CANTAB paired associate learning (PAL) to that of an established and validated noncomputerized test, the CERAD Wordlist Learning task in differentiating between normal aging, aMCI and AD in a cross-sectional design.
METHODS: 58 participants were assessed (19 with mild probable AD, 17 aMCI, 22 healthy controls).
RESULTS: The variables found to best discriminate between the three groups were the CANTAB PAL total errors adjusted (p < 0.0001, 81.0% of the cases correctly classified), and CERAD Wordlist Learning Delayed Recall (p < 0.0001, 77.6% of the cases correctly classified). Using both PAL total errors adjusted and Wordlist Learning Delayed Recall, 84.5% of the cases were correctly classified. DISCUSSION: The results suggest that the CANTAB could be used for screening of AD-typical memory impairment.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22922741     DOI: 10.1159/000342116

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  19 in total

1.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

2.  Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior.

Authors:  Anja Soldan; Corinne Pettigrew; Abhay Moghekar; Marilyn Albert
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

3.  A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease.

Authors:  Cheng-Hsuan Li; Ta-Fu Chen; Pei-Ling Peng; Chin-Hsien Lin
Journal:  J Neurol       Date:  2022-08-14       Impact factor: 6.682

4.  The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.

Authors:  Jane Alty; Quan Bai; Renjie Li; Katherine Lawler; Rebecca J St George; Edward Hill; Aidan Bindoff; Saurabh Garg; Xinyi Wang; Guan Huang; Kaining Zhang; Kaylee D Rudd; Larissa Bartlett; Lynette R Goldberg; Jessica M Collins; Mark R Hinder; Sharon L Naismith; David C Hogg; Anna E King; James C Vickers
Journal:  BMC Neurol       Date:  2022-07-18       Impact factor: 2.903

5.  Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach.

Authors:  Robbert L Harms; Alberto Ferrari; Irene B Meier; Julie Martinkova; Enrico Santus; Nicola Marino; Davide Cirillo; Simona Mellino; Silvina Catuara Solarz; Ioannis Tarnanas; Cassandra Szoeke; Jakub Hort; Alfonso Valencia; Maria Teresa Ferretti; Azizi Seixas; Antonella Santuccione Chadha
Journal:  EPMA J       Date:  2022-06-06       Impact factor: 8.836

6.  Computerized paired associate learning performance and imaging biomarkers in older adults without dementia.

Authors:  Corinne Pettigrew; Anja Soldan; Rostislav Brichko; Yuxin Zhu; Mei-Cheng Wang; Kwame Kutten; Murat Bilgel; Susumu Mori; Michael I Miller; Marilyn Albert
Journal:  Brain Imaging Behav       Date:  2021-10-23       Impact factor: 3.224

Review 7.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

8.  Revision of the Cognitive Assessment for Dementia, iPad version (CADi2).

Authors:  Keiichi Onoda; Shuhei Yamaguchi
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

9.  CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study.

Authors:  Fernanda Cabral Soares; Thaís Cristina Galdino de Oliveira; Liliane Dias e Dias de Macedo; Alessandra Mendonça Tomás; Domingos Luiz Wanderley Picanço-Diniz; João Bento-Torres; Natáli Valim Oliver Bento-Torres; Cristovam Wanderley Picanço-Diniz
Journal:  Clin Interv Aging       Date:  2014-12-19       Impact factor: 4.458

10.  Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease.

Authors:  Jurgita Kuzmickienė; Gintaras Kaubrys
Journal:  Med Sci Monit       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.